Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CytRx Corp (NASDAQ:CYTR)

0.558
Delayed Data
As of 1:54pm ET
 -0.0031 / -0.55%
Today’s Change
0.55
Today|||52-Week Range
3.66
-78.94%
Year-to-Date
No recent news for CytRx Corp.

Today’s Trading

Previous close0.56
Today’s open0.56
Day’s range0.56 - 0.57
Volume1,041,385
Average volume (3 months)2,093,424
Market cap$54.4M
Dividend yield--
Data as of 1:54pm ET, 09/27/2016

Growth & Valuation

Earnings growth (last year)-76.36%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales1,602.80
Price/Book0.85

Competitors

 Today’s
change
Today’s
% change
APVOAptevo Therapeutics ...+0.04+1.33%
DNAIProNAi Therapeutics ...+0.01+0.80%
PLXProtalix Biotherapeu...-0.01-1.28%
VSTMVerastem Inc-0.02-1.45%
Data as of 2:07pm ET, 09/27/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$100.0K
Annual profit (last year)-$58.6M
Net profit margin-58,587.19%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Steven A. Kriegsman
Chief Financial Officer &
Treasurer
John Y. Caloz
Corporate headquarters
Los Angeles, California

Forecasts

Search for Jobs